Affymax N.V. regulatory update

The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired for Glaxo's tender offer to purchase all of AFMXF's shares for $30 per share (see BioCentury Extra, Jan. 27). The tend...